1. CD28 is expressed by macrophages with anti‐inflammatory potential and limits their T‐cell activating capacity. Issue 4 (24th November 2020) Authors: Estrada‐Capetillo, Lizbeth; Aragoneses‐Fenoll, Laura; Domínguez‐Soto, Ángeles; Fuentelsaz‐Romero, Sara; Nieto, Concha; Simón‐Fuentes, Miriam; Alonso, Bárbara; Portolés, Pilar; Corbí, Angel L.; Rojo, Jose M.; Puig‐Kröger, Amaya Journal: European journal of immunology Issue: Volume 51:Issue 4(2021) Page Start: 824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characteristics of TCR/CD3 complex CD3ɛ chains of regulatory CD4+ T (Treg) lymphocytes: role in Treg differentiation in vitro and impact on Treg in vivo. Issue 3 (8th November 2013) Authors: Rojo, Jose M.; Ojeda, Gloria; Acosta, Yenny Y.; Montes‐Casado, Maria; Criado, Gabriel; Portolés, Pilar Journal: Journal of leukocyte biology Issue: Volume 95:Issue 3(2014) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characteristics of TCR/CD3 complex CD3ɛ chains of regulatory CD4+ T (Treg) lymphocytes: role in Treg differentiation in vitro and impact on Treg in vivo. Issue 3 (8th November 2013) Authors: Rojo, Jose M; Ojeda, Gloria; Acosta, Yenny Y; Montes-Casado, Maria; Criado, Gabriel; Portolés, Pilar Journal: Journal of leukocyte biology Issue: Volume 95:Issue 3(2014) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 10295 (10th July 2021) Authors: Borobia, Alberto M; Carcas, Antonio J; Pérez-Olmeda, Mayte; Castaño, Luis; Bertran, María Jesús; García-Pérez, Javier; Campins, Magdalena; Portolés, Antonio; González-Pérez, María; García Morales, María Teresa; Arana-Arri, Eunate; Aldea, Marta; Díez-Fuertes, Francisco; Fuentes, Inmaculada; Ascaso... Journal: Lancet Issue: Volume 398:Issue 10295(2021) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 10295 (10th July 2021) Authors: Borobia, Alberto M; Carcas, Antonio J; Pérez-Olmeda, Mayte; Castaño, Luis; Bertran, María Jesús; García-Pérez, Javier; Campins, Magdalena; Portolés, Antonio; González-Pérez, María; García Morales, María Teresa; Arana-Arri, Eunate; Aldea, Marta; Díez-Fuertes, Francisco; Fuentes, Inmaculada; Ascaso... Journal: Lancet Issue: Volume 398:Issue 10295(2021) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Role of endocytosis and trans-endocytosis in ICOS costimulator-induced downmodulation of the ICOS Ligand. Issue 5 (2nd February 2021) Authors: Aragoneses-Fenoll, Laura; Montes-Casado, María; Ojeda, Gloria; García-Paredes, Lucía; Arimura, Yutaka; Yagi, Junji; Dianzani, Umberto; Portolés, Pilar; Rojo, José M Journal: Journal of leukocyte biology Issue: Volume 110:Issue 5(2021) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand. Issue 5 (2nd February 2021) Authors: Aragoneses‐Fenoll, Laura; Montes‐Casado, María; Ojeda, Gloria; García‐Paredes, Lucía; Arimura, Yutaka; Yagi, Junji; Dianzani, Umberto; Portolés, Pilar; Rojo, José M. Journal: Journal of leukocyte biology Issue: Volume 110:Issue 5(2021) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗